BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37917375)

  • 1. Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells.
    Kazimierska M; Leśniewska A; Bakker A; Diepstra A; Kasprzyk ME; Podralska M; Rassek K; Kluiver J; van den Berg A; Rozwadowska N; Dzikiewicz-Krawczyk A
    J Appl Genet; 2024 Feb; 65(1):95-101. PubMed ID: 37917375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal ovarian upregulation of glutamate cysteine ligase expression in response to suppression of glutathione by buthionine sulfoximine.
    Hoang YD; Avakian AP; Luderer U
    Reprod Toxicol; 2006 Feb; 21(2):186-96. PubMed ID: 16183247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis.
    Lopez SG; Luderer U
    Free Radic Biol Med; 2004 Jun; 36(11):1366-77. PubMed ID: 15135172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
    Rappa G; Gamcsik MP; Mitina RL; Baum C; Fodstad O; Lorico A
    Eur J Cancer; 2003 Jan; 39(1):120-8. PubMed ID: 12504668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
    Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
    Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
    Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-S,R-buthionine sulfoximine: historical development and clinical issues.
    Bailey HH
    Chem Biol Interact; 1998 Apr; 111-112():239-54. PubMed ID: 9679558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments.
    Galván I; Wakamatsu K; Alonso-Alvarez C; Solano F
    Bioorg Med Chem Lett; 2014 May; 24(9):2150-4. PubMed ID: 24703231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies.
    Dos Reis Oliveira C; Pereira JC; Barros Ibiapina A; Roseno Martins IR; de Castro E Sousa JM; Ferreira PMP; Carneiro da Silva FC
    J Toxicol Environ Health B Crit Rev; 2023 Nov; 26(8):417-441. PubMed ID: 37606035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of D,L-buthionine-S,R-sulfoximine on the ratio of glutathione forms and the growth of tatar buckwheat calli].
    Nigmatullina LR; Rumiantseva NI; Kostiukova IuA
    Ontogenez; 2014; 45(1):50-62. PubMed ID: 25720265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin B-induced increase in cellular glutathione level and protection against oxidant injury are mediated by the enhancement of glutathione synthesis and regeneration in AML12 and H9c2 cells.
    Chiu PY; Ko KM
    Biofactors; 2006; 26(4):221-30. PubMed ID: 17119269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.
    Tanaka T; Uchiumi T; Kohno K; Tomonari A; Nishio K; Saijo N; Kondo T; Kuwano M
    Biochem Biophys Res Commun; 1998 May; 246(2):398-403. PubMed ID: 9610371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP; Zonis S; al-Bassam M; Kyshtoobayeva A; Dasgupta C; Milovanovic T; Parker RJ; Buzaid AC
    Chem Biol Interact; 1998 Apr; 111-112():277-305. PubMed ID: 9679561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
    Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
    Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
    Lorico A; Bratbak D; Meyer J; Kunke D; Krauss S; Plott WE; Solodushko V; Baum C; Fodstad O; Rappa G
    Hum Gene Ther; 2005 Jun; 16(6):711-24. PubMed ID: 15960602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of cellular glutathione levels in human ABCB5- and murine Abcb5-transfected cells.
    Kondo S; Hongama K; Hanaya K; Yoshida R; Kawanobe T; Katayama K; Noguchi K; Sugimoto Y
    BMC Pharmacol Toxicol; 2015 Dec; 16():37. PubMed ID: 26666373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
    Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
    Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.